EXPANDCOLLAPSE

• +Healthcare Professionals
  • +Diabetes care
    • Pharmaceuticals
      • Levemir®
        • Action profile
        • Treatment guidelines
        • Prescribing information
        • Product benefits
          • Once daily efficacy
          • Weight benefit
          • Safety
          • Basal/bolus therapy
        • Clinical data
        • PREDICTIVE study
        • Suitable devices
      • NovoMix® 30
        • Action profile
        • Treatment guidelines
        • Prescribing information
        • Product benefits
          • PPG & FPG control
          • HbA1C control
          • Simple and convenient
        • Clinical data
        • Testimonials
          • Britt-Marie - Sweden
          • Susan - Denmark
          • Talat - Turkey
        • Suitable devices
      • NovoRapid®
        • Action profile
        • Treatment guidelines
        • Prescribing information
        • Product benefits
          • Superior postprandial control
          • Improved long-term control
          • Basal-bolus therapy
          • Reduced nocturnal hypoglycaemia
          • Flexibility around meals
          • Paediatric use
          • Simple pen dosing
        • Clinical data
        • Suitable devices
        • NovoRapid® in pump therapy
          • Pump therapy clinical data
          • Abbreviated prescribing information
      • Actrapid®
        • Action profile
        • Treatment guidelines
        • Prescribing information
        • Suitable devices
      • Insulatard®
        • Action profile
        • Treatment guidelines
        • Prescribing information
        • Suitable devices
      • Mixtard®
        • Action profiles
        • Treatment guidelines
        • Prescribing information
        • Suitable devices
      • GlucaGen® HypoKit
        • Product benefits
        • Prescribing information
        • Manual
        • Quick Guide
        • Demo
        • Case stories
          • Mild & moderate hypo
          • Severe hypo
      • NovoNorm®
        • Clinical data
          • Clinical impact of postprandial hyperglycaemia
          • Pathophysiology of type 2 diabetes
          • Reduced elevated postprandial blood glycaemia
          • Comprehensive control
          • Effective glycaemic control
          • Effective antidiabetic agent
          • Effective in combination therapy
          • No risk of weight gain
          • Low risk of hypoglycaemia
        • Treatment guidelines
          • Recommended starting doses
          • Patient selection
          • Combination therapy
          • What is considered a meal?
        • Prescribing information
        • Product benefits
          • Reduced elevated postprandial blood glucose
          • Lower fasting blood glucose and HbA1c
          • Control without compromise
        • FAQ
          • General
          • Efficacy
          • Safety
          • Weight profile
          • Dosing
          • Combination therapy
      • R&D Pipeline
    • Injection devices
      • FlexPen®
        • Product benefits
        • FAQ
        • Handling data
        • Quick Guide
        • Product photo
      • NovoPen® 4
        • Product benefits
        • Compatibility
        • FAQ
        • eManual
        • Clinical data
        • Product photo
      • NovoPen® 3
        • Product benefits
        • Compatibility
        • FAQ
        • Manual
        • QuickGuide
        • Product photo
        • NovoPen® 3 Demi
          • Product benefits
          • Compatibility
          • FAQ
          • Manual
          • QuickGuide
          • Product photo
        • PenMate®
          • Product benefits
          • Manual
          • QuickGuide
          • Product photo
      • NovoPen® Junior
        • Product benefits
        • Compatibility
        • FAQ
        • Manual
        • QuickGuide
        • Product photo
      • InnoLet®
        • Product benefits
        • Handling data
        • FAQ
        • Maintenance
        • QuickGuide
        • Product photo
      • NovoLet®
        • Product benefits
        • FAQ
        • QuickGuide
        • Product photo
      • Innovo®
        • Manual
      • InDuo®
        • Manual
    • Needles
      • NovoFine®
        • Product benefits
          • Comfortable
          • Consistent and effective
          • Easy to use
        • Product range
        • FAQ
        • Maintenance
        • Manual
        • QuickGuide
        • Suitable devices
        • Product photo
      • NovoFine® Autocover®
        • Product benefits
          • Safety
          • Hidden needle
          • Eliminates needle re-use
        • Manual
        • QuickGuide
        • Demo
        • Suitable devices
        • Product photo
    • Public
  • +Growth hormone therapy
    • Pharmaceutical info
      • Norditropin®
        • Benefits
          • Stable at room temperature
          • Easy to use
          • Less pain
          • Preferred by patients
        • Treatment areas
          • GHD
          • GHDA
          • SGA
          • Turner syndrome
          • Skeletal dysplasia
          • Chronic renal disease
        • Prescribing info
        • Handling info
        • Patients' FAQ
          • About Norditropin®
          • About injecting growth hormone
        • Our history in GH therapy
    • Injection devices
      • Norditropin NordiFlex®
        • Benefits
          • Easy to use
          • Convenience & compliance
          • Easy to teach
          • Accurate dosing
          • Less pain
          • Optimal comfort
          • Preferred by patients
        • Demo
        • Quick guide
        • Prescribing info
        • Handling info
        • Patients' FAQ
          • About Norditropin NordiFlex®
          • About injecting growth hormone
        • NordiFlex PenMate™
          • Benefits
          • Patients' FAQ
      • NordiFlex PenMateTM
      • NordiPen®
        • Benefits
          • Stable at room temperature
          • Less pain
          • Optimal comfort
          • Wide choice
          • Preferred by patients
        • Quick guide
        • Prescribing info
        • Handling info
        • Patients' FAQ
          • About NordiPen®
          • About injecting growth hormone
        • NordiPenMate®
          • Benefits
          • Quick guide
          • Patients' FAQ
      • NordiPenMate®
      • Norditropin® NordiLet®
        • Benefits
          • Easy to use
          • Convenience & compliance
          • Simple, flexible, accurate dosing
          • Less pain
          • Optimal comfort
          • Preferred by patients
        • Demo
        • Quick guide
        • Conversion module
        • Prescribing info
        • Handling info
        • Patients' FAQ
          • About Norditropin® NordiLet®
          • About injecting growth hormone
      • NovoFine® needles
        • Benefits
          • Comfortable
          • Consistent & effective
          • Easy to use
        • Product range
        • Maintenance
        • Patients' FAQ
    • Disease areas
      • GHD (Growth hormone deficiency)
      • GHDA (Growth hormone deficiency in adults)
      • SGA (Small for gestational age)
      • Turner syndrome
      • Skeletal dysplasia
      • Chronic renal disease
    • Services & links
      • NordiNet® outcomes research
        • International Outcome Study
        • Investigator studies
        • Patient management
      • SGA tutorial
      • Educational programme (PEEP)
      • Research fellowships (ESPE)
      • Literature
      • Patient community
      • Patient tutorial
      • Our commitment to GH therapy
      • Links
    • Public
  • +Haemostasis management
    • Product info
      • NovoSeven®
        • Treatment areas
          • Haemophilia
          • Factor VII deficiency
          • Glanzmann's thrombasthenia
        • Prescribing information
          • SPC
          • Monitoring therapeutic effects
          • Effects of NovoSeven® on prothrombin time
          • Effects of NovoSeven® on activated partial thromboplastin time
          • Monitoring by plasma FVIIa levels
          • Monitoring for possible systemic activation of coagulation
        • Mode of action
        • Safety & efficacy
          • Manufacturing & product safety
          • Pre-clinical safety & efficacy studies
          • Therapeutic efficacy & clinical safety
          • Clinical safety since launch
        • Pharmacokinetics & pharmacodynamics
        • Healthcare Professional FAQ
          • Using NovoSeven® to treat Haemophilia
          • Using NovoSeven® to treat Factor VII deficiency
          • Using NovoSeven® to treat Glanzmann's thrombasthenia
        • Patients' FAQ
          • Using NovoSeven® to treat Haemophilia
          • Using NovoSeven® to treat Factor VII deficiency
          • Using NovoSeven® to treat Glanzmann's thrombasthenia
        • Product monograph
      • Single Dose
        • Single Dose benefits
        • Clinical study reviews
          • Kavakli et al. 2006
          • Santagostino et al. 2006
        • Single Dose virtual symposium
      • Room temperature stable
    • Haemostasis
      • Management
        • History of haemostasis management
          • Evolution of knowledge of coagulation
          • A brief history of blood transfusion
          • Evolution of blood component therapy
        • Blood - it's use in haemostasis management
          • Blood use - some statistics
          • Risks associated with blood transfusion
          • Screening tests
          • Guidelines for the collection & storage of blood
          • Summary - blood products in haemostasis management
          • Further reading
        • Haemotological testing
          • Coagulation cascade
          • Basic blood tests
          • Coagulation tests
          • Assays of specific factors
          • Testing for the presence of coagulation & fibrinolytic inhibitors
          • Indicators of thrombosis
          • Platelet function tests
          • Haemostatic tests under investigation
        • Treatment guidelines
      • Blood coagulation
        • Normal coagulation
        • The components of coagulation
        • Disseminated intravascular coagulation (DIC)
        • Control mechanisms in haemostasis
    • Disease areas
      • Congenital haemophilia
        • Haemophilia A & B
          • History
          • Incidence & heredity
          • Types & severity
          • Bleeds & treatment
          • Surgery
        • Haemophilia with inhibitors
          • Incidence of inhibitors
          • Measuring inhibitors
          • Prognosis for inhibitor patients
          • Treatment options for inhibitor patients
          • Long-term strategies
          • Surgery
      • Acquired haemophilia
        • Incidence & aetiology
        • Clinical & laboratory features
        • Incidence of haemorrhage
        • Management
        • Case reports
      • Factor VII deficiency
        • Pathology
        • Heredity
        • Laboratory tests
        • Bleeding episodes
        • Current treatment options
      • Glanzmann's thrombasthenia
        • Pathology
        • Heredity
        • Laboratory tests
        • Bleeding episodes
        • Current treatment options
    • Educational
      • Key papers
        • Home treatment
        • Surgery in haemophilia
        • Bleeding in haemophilia
        • Acquired haemophilia
        • Factor VII deficiency
        • Glanzmann's thrombasthenia
        • Dosage & pharmacokinetics
        • FVIII & FIX antibodies
        • Reviews
        • Preclinical
        • Other
      • Treatment guidelines
      • Services & links
      • WFH patients' leaflet
        • Why do people with haemophilia bleed?
        • The blood clotting process
        • What can be done to stop bleeding in people with haemophilia?
        • Treatment of people with haemophilia & inhibitors using NovoSeven®
        • Further reading
      • Patient stories
        • Hamish & Tom, Australia
        • Marc, Canada
    • Public
  • +Hormone replacement therapy
    • Our products
      • Introduction
      • Activelle®
      • Novofem®
      • Estrofem®
      • Vagifem®
      • Convenience & compliance
      • Our history in HRT
    • About HRT
      • Introduction
      • Symptoms & complaints
      • Duration of treatment
      • Oestrogen
      • Progestogen
      • Continuous combined HRT
      • Sequential combined HRT
      • Low-dose HRT
    • Educational resources
      • Services & links
    • Public
• +Patients
  • +Diabetes care
    • Insulin pens
      • FlexPen®
        • Product benefits
        • Testimonials
        • FAQ
        • Maintenance
        • Quick Guide
        • Product photo
      • NovoPen® 4
        • Product benefits
        • Compatibility
        • FAQ
        • Maintenance
        • eManual
        • Product photo
      • NovoPen® 3
        • Product benefits
        • Testimonials
        • FAQ
        • Maintenance
        • Manual
        • QuickGuide
        • Product photo
        • NovoPen® 3 Demi
          • Product benefits
          • FAQ
          • Maintenance
          • Manual
          • QuickGuide
          • Product photo
        • PenMate®
          • Product benefits
          • Testimonials
          • Maintenance
          • Manual
          • QuickGuide
          • Product photo
      • NovoPen® Junior
        • Product benefits
        • Testimonials
        • FAQ
        • Maintenance
        • Manual
        • QuickGuide
        • Product photo
      • InnoLet®
        • Product benefits
        • Testimonials
        • FAQ
        • Maintenance
        • QuickGuide
        • Product photo
      • NovoLet®
        • Product benefits
        • Testimonials
        • FAQ
        • Maintenance
        • QuickGuide
        • Product photo
      • Innovo®
        • Manual
      • InDuo®
        • Manual
    • Needles
      • NovoFine®
        • Product benefits
          • Comfortable
          • Consistent and effective
          • Easy to use
        • Product range
        • FAQ
        • Maintenance
        • Manual
        • QuickGuide
        • Suitable devices
        • Testimonials
        • Product photo
      • NovoFine® Autocover®
        • Product benefits
          • Safety
          • Hidden needle
          • Eliminates needle re-use
        • Manual
        • QuickGuide
        • Demo
        • Suitable devices
        • Product photo
    • HypoKit
      • GlucaGen® HypoKit
        • Product benefits
        • FAQ
        • Maintenance
        • Manual
        • QuickGuide
        • Demo
        • Case stories
          • Mild & moderate hypo
          • Severe hypo
        • Product photo
    • Diabetes tools
      • Hands On Insulin
      • Living with diabetes
        • What is diabetes?
          • Why did I get diabetes?
          • What happens in diabetes?
          • Am I at risk?
          • Treating diabetes
        • Keeping well with diabetes
          • Stress & illness
          • Complications
        • Exercise
          • Tips to getting started
          • Your exercise program
          • Adventure sports
        • Travelling
          • Preparing to travel
          • During travel
          • Our expert advice
      • For parents
        • Treatment & healthy growth
          • Insulin
          • Assessment
          • Complications
          • Key tips
          • When to seek emergency help
        • For teachers
          • What is diabetes?
          • Blood sugar levels
          • Sports and activity
      • For children
        • What is diabetes?
        • You & your body
          • Low blood sugar
          • High blood sugar
        • At school & at play
          • What to tell friends
          • At play
          • At school
      • All about food
        • Diabetes & sugar
        • Goals & guidelines
        • Planning your meals
          • Role of fibre
          • Reading food labels
        • Alcohol
          • Alcohol & hypoglycaemia
        • Healthy tips
      • Communities
      • Hypoglycaemia
        • What is a Hypo?
        • What causes a Hypo?
        • What are the symptoms?
        • Mild and moderate Hypos
          • Case story
        • Severe Hypos
          • Case story
        • After a Hypo
      • Insulins
    • Professionals
  • +Growth hormone therapy
    • Phamaceutical info
      • Human growth hormone (hGH)
    • Injection pens
      • NordiFlex®
        • Benefits
          • Easy to use
          • Convenience & compliance
          • Easy to teach
          • Accurate dosing
          • Less pain
          • Optimal comfort
          • Preferred by patients
        • Demo
        • Quick guide
        • Handling info
        • FAQ
          • About NordiFlex®
          • About injecting growth hormone
        • NordiFlex PenMate™
          • Benefits
          • FAQ
      • NordiFlex PenMateTM
      • NordiPen®
        • Benefits
          • Stable at room temperature
          • Less pain
          • Optimal comfort
          • Wide choice
          • Preferred by patients
        • Quick guide
        • Handling info
        • FAQ
          • About NordiPen®
          • About injecting growth hormone
        • NordiPenMate®
          • Benefits
          • Quick guide
          • FAQ
      • NordiPenMate®
      • NordiLet®
        • Benefits
          • Easy to use
          • Convenience & compliance
          • Simple, flexible, accurate dosing
          • Less pain
          • Optimal comfort
          • Preferred by patients
        • Demo
        • Quick guide
        • Conversion module
        • Handling info
        • FAQ
          • About NordiLet®
          • About injecting growth hormone
      • NovoFine® needles
        • Benefits
          • Comfortable
          • Consistent & effective
          • Easy to use
        • Product range
        • Maintenance
        • FAQ
    • Growth disorders
      • What is growth hormone?
      • GHD (Growth hormone deficiency)
      • GHDA (Growth hormone deficiency in adults)
      • SGA (Small for gestational age)
      • Turner syndrome
      • Skeletal dysplasia
      • Chronic renal disease
    • Learn more
      • Interactive tutorial
      • Patient stories
        • Neil - GHD
        • Max - SGA
        • Nagisa - Turner syndrome
      • Patient community
      • Our commitment to GH therapy
      • Links
    • Professionals
  • +Haemostasis management
    • Product info
      • Recombinant factor VIIa
    • Haemostasis
      • What is haemostasis?
      • Haemostasis management
    • Disease areas
      • Introduction
      • Congenital haemophilia
      • Acquired haemophilia
      • Factor VII deficiency
      • Glanzmann's thrombasthenia
    • Educational
      • Links
      • Patient story
    • Professionals
  • +Hormone replacement therapy
    • About HRT
      • Introduction
      • Duration of treatment
      • Oestrogen
      • Progestogen
      • Continuous combined HRT
      • Sequential combined HRT
      • Low-dose HRT
    • About the menopause
      • Introduction
      • Symptoms & complaints
      • Hormonal interaction
      • Hormonal imbalance
      • Atrophic vaginitis
    • Professionals
• +Investors
  • News
  • Novo Nordisk in short
    • Key facts
    • Dividend policy
    • Financial targets
    • Rating strategy
  • Calendar
  • Download centre
  • Conference calls
  • Corporate Governance
  • IR guidelines
  • IR Contacts
  • R&D pipeline
  • Share information
    • Facts about the share
    • Trading in shares
    • Disclosure obligations of major shareholders
    • Dividend and capital history
    • Downloadable financial data
    • Analyst coverage
    • Biograhies of Novo Nordisk Executive Management
  • Sustainability
  • Subscription
  • FAQ
• +Media
  • News
  • Facts about Novo Nordisk
  • R&D pipeline
  • Download centre
  • Diabetes dictionary
  • Broadcast room
  • Photos
  • Subscription service
  • Novo Nordisk Media Prize
    • 2007 winners
    • Photos
  • Contact
• +R&D
  • R&D at a glance
  • About R&D
    • Organisation
    • Diabetes Research Unit
    • Biopharmaceuticals Research Unit
    • Global Development
    • Chemistry, Manufacturing and Control Supply
    • Regulatory Affairs
  • Pipeline
    • Diabetes
    • Growth Hormone
    • Haemostasis
    • Other therapies
  • Partnering
    • Why partner with us?
    • Diabetes
    • Protein Delivery
    • Haemophilia
    • Growth disorders
    • Inflammation
    • Partnerships
    • Protein expertise
    • Clinical research partnerships
    • Novo Nordisk Biotech Fund
    • Contact us
  • Scientific publications
  • Bioethics
    • Bioethics governance
    • Clinical trial ethics
    • Stem cell ethics
    • Animal ethics
    • Animal welfare
    • Gene technology ethics
  • From idea to patient
  • Fellowships
    • Return fellowships
    • Co-financed PhD fellowships
    • Scholarships
  • Novo Nordisk Trials
  • Contact us
• +Jobs
  • Working at Novo Nordisk
    • Testimonials
    • What makes us tick
    • Once you're in
    • Programmes for you
    • Reputation - inside and out
    • Doing it the right way
    • Locations
  • Jobs
  • MD and scientist programmes
    • Return Fellowships for Danish Scientists
    • Pharmaceutical Medicine Programme
  • Graduate programmes
    • Business IT
    • Global Finance
    • Business Processes
    • International Marketing
    • Supply Chain
    • Region Europe Finance
    • Region Europe Pharma Mgt
    • International Operations Finance
    • Novo Nordisk, USA
    • R&D - Regulatory Affairs
    • R&D - Global Development
  • Elever
    • Kokkeelev
    • Kontorelev
    • Laborantpraktikant
    • Procesoperatørelev
    • Værktøjsmagerlærling
    • Økonomielev
    • Automatikfagtekniker- lærling
    • Dyrepasserelev
    • Industrielektriker- lærling
    • Industriteknikerlærling
    • Klejnsmedslærling
  • Meet Novo Nordisk
  • Tips for your application
    • The hiring process
    • The application
    • The interview
    • Use of personality test
    • Unsolicited application
  • Contact us
• +Sustainability
  • Sustainability in short
    • Economically viable
    • Socially responsible
    • Environmentally responsible
  • Corporate sustainability
  • Vision and strategy
    • Strategy
  • Values in action
    • Access to health
    • Advocacy
    • Bioethics
    • Business ethics
    • Community engagement
    • Environmental management
    • Financial performance
    • Human rights
    • Legal issues
    • Quality
    • Responsible sourcing
    • Socio-economics
    • Tax
    • Workplace quality
    • Key performance data
    • Assurance
  • Stakeholder engagement
    • Partnerships
    • Memberships
    • Stakeholder feedback
  • Governance
    • Corporate governance
    • Codes, standards and practices
    • Compliance
    • Risk management
    • Assurance
  • Positions
    • Access to health
    • Animal experimentation
    • Climate change
    • Clinical trials
    • Gene technology
    • Human rights
    • Intellectual property rights
    • Non-human primates
    • Stem cells
  • Reporting
    • GRI
    • Global Compact
    • Green accounts
    • Reporting strategy
    • Reports
    • Create your own PDF file
  • Awards and recognition
  • News archive
  • Around the world
  • Interactive challenges
    • The Business Ethics Challenge
    • The EnviroMan
    • The Convincer
  • Contact us
  • Order the Annual Report 2007
• +About us
  • Novo Nordisk in brief
    • Ownership
    • Facts and figures
    • History
    • Our logo
  • Novo Nordisk way of management
    • Our vision
    • The charter
    • The policies
    • View PDF file
  • Management
    • Board of Directors
    • Executive Management
  • Corporate governance
    • Governance model
    • Shareholder Rights
    • Novo Nordisk Foundation
    • General meetings and Shareholders meeting
    • Board of Directors
    • Chairmanship and board committees
    • Audit Committee
    • Executive Management
    • Remuneration policy
    • Self-assessment
    • Risk management
    • Internal control
    • Assurance
    • Audit
    • Benchmark 2007
    • Codes and practices
  • Global offices
  • Changing diabetes
    • About changing diabetes
    • Novo Nordisk brand
    • Young Voices
    • Young Voices book
    • School Challenge
    • World Diabetes Foundation
    • UN Resolution
    • Leadership Forum
    • Changing diabetes barometer
    • Changing Diabetes e-newsletter
  • Changing possibilities in haemophilia
    • Foundation
    • History
  • Novo Nordisk youth panel
    • About the youth panel
    • Tools of engagement
    • Meet the advocates
  • Download centre
  • Contact us